等待開盤 11-19 09:30:00 美东时间
+0.570
+0.19%
Analysts upgraded UNFI, ZBH, NUE, MDT and PRAX, raising price targets and ratings to Buy or Overweight.
11-17 21:26
KKR headlines Monday’s reports, with investors weighing whether fundraising momentum can offset a sharp year-to-date stock decline. Constellation Energy, Barrick Mining, Ferguson Enterprises and ORIX report before the
11-09 04:31
Praxis Precision Medicines reports mixed Phase 2/3 POWER1 results for vormatrigine, with higher-dose data showing stronger seizure reduction.
06-02 18:09
Praxis Precision Medicines shares are trading higher Monday after it announced positive results from the EMBRAVE Part A Trial of Elsunersen.
04-06 21:08
Xenon Pharmaceuticals shares surge after Phase 3 data show strong seizure reduction for azetukalner, with FDA filing planned for 2026.
03-09 21:26
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) reported a wider-than-expected l...
02-21 01:10
Praxis Precision Medicine (NASDAQ:PRAX) reported its Q4 earnings results on Thu...
02-19 20:40
Companies Reporting Before The Bell • Deere (NYSE:DE) is expected to report qua...
02-19 19:11
Praxis Precision Medicine (NASDAQ:PRAX) will release its quarterly earnings rep...
02-19 00:02
Praxis Precision Medicines Inc (NASDAQ: PRAX) stock rose after FDA granted BTD for ulixacaltamide to treat essential tremor.
2025-12-30 01:21